2 citations · 3 across the 4 of their papers we have counts for
5 papers
Does your cost-effectiveness model answer the question of interest? Marginal versus conditional inputs and transportability across populations
Jeroen P. Jansen, Harlan Campbell, Shannon Cope +2
Objectives: There has been increased appreciation of the differences between marginal and conditional estimates and different types of effect measures regarding their applicability…
Marginal and conditional summary measures: transportability and compatibility across studies
Antonio Remiro-Azócar, David M. Phillippo, Nicky J. Welton +4
Marginal and conditional summary measures do not generally coincide, have different interpretations and correspond to different decision questions. While these aspects have primari…
Doubly robust augmented weighting estimators for the analysis of externally controlled single-arm trials and unanchored indirect treatment comparisons
Harlan Campbell, Antonio Remiro-Azócar
Externally controlled single-arm trials are critical to assess treatment efficacy across therapeutic indications for which randomized controlled trials are not feasible. A closely-…
Estimands and Their Implications for Evidence Synthesis for Oncology: A Simulation Study of Treatment Switching in Meta-Analysis
Rebecca K. Metcalfe, Antonio Remiro-Azócar, Quang Vuong +4
The ICH E9(R1) addendum provides guidelines on accounting for intercurrent events in clinical trials using the estimands framework. However, there has been limited attention to the…
Marginalization of Regression-Adjusted Treatment Effects in Indirect Comparisons with Limited Patient-Level Data
Antonio Remiro-Azócar, Anna Heath, Gianluca Baio
Population adjustment methods such as matching-adjusted indirect comparison (MAIC) are increasingly used to compare marginal treatment effects when there are cross-trial difference…